[HTML] sciencedirect.com

[HTML][HTML] Immunotherapy for hepatocellular carcinoma: current status and future perspectives

T Okusaka, M Ikeda - ESMO open, 2018 - Elsevier
The discovery of the immune checkpoint mechanism has contributed greatly to recent
advances in cancer treatment. The anticytotoxic T lymphocyte-associated protein 4 antibody …
被引用次数：89 相关文章

Immunotherapy for hepatocellular carcinoma: current status and future perspectives

T Okusaka, M Ikeda - ESMO open, 2018 - pubmed.ncbi.nlm.nih.gov
The discovery of the immune checkpoint mechanism has contributed greatly to recent
advances in cancer treatment. The anticytotoxic T lymphocyte-associated protein 4 antibody …
[HTML] esmoopen.com

[HTML][HTML] Immunotherapy for hepatocellular carcinoma: current status and future perspectives

T Okusaka, M Ikeda - ESMO Open, 2018 - esmoopen.com
The discovery of the immune checkpoint mechanism has contributed greatly to recent
advances in cancer treatment. The anticytotoxic T lymphocyte-associated protein 4 antibody …

Immunotherapy for hepatocellular carcinoma: current status and future perspectives.

T Okusaka, M Ikeda - ESMO Open, 2018 - europepmc.org
The discovery of the immune checkpoint mechanism has contributed greatly to recent
advances in cancer treatment. The anticytotoxic T lymphocyte-associated protein 4 antibody …
[HTML] nih.gov

[HTML][HTML] Immunotherapy for hepatocellular carcinoma: current status and future perspectives

T Okusaka, M Ikeda - ESMO Open, 2018 - ncbi.nlm.nih.gov
The discovery of the immune checkpoint mechanism has contributed greatly to recent
advances in cancer treatment. The anticytotoxic T lymphocyte-associated protein 4 antibody …